FinTrust Capital Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $105 | Hold |
14
| – | – | ﹤0.01% | 1339 |
|
2024
Q2 | $125 | Hold |
14
| – | – | ﹤0.01% | 1316 |
|
2024
Q1 | $142 | Hold |
14
| – | – | ﹤0.01% | 1220 |
|
2023
Q4 | $141 | Hold |
14
| – | – | ﹤0.01% | 1195 |
|
2023
Q3 | $132 | Sell |
14
-2,500
| -99% | -$23.6K | ﹤0.01% | 1187 |
|
2023
Q2 | $63.6K | Hold |
2,514
| – | – | 0.02% | 406 |
|
2023
Q1 | $63.6K | Hold |
2,514
| – | – | 0.02% | 407 |
|
2022
Q4 | $63.6K | Hold |
2,514
| – | – | 0.02% | 408 |
|
2022
Q3 | $54K | Buy |
2,514
+2,499
| +16,660% | +$53.7K | 0.01% | 497 |
|
2022
Q2 | $0 | Sell |
15
-2,000
| -99% | – | ﹤0.01% | 1313 |
|
2022
Q1 | $51K | Hold |
2,015
| – | – | 0.01% | 558 |
|
2021
Q4 | $84K | Buy |
+2,015
| New | +$84K | 0.02% | 454 |
|
2021
Q3 | – | Sell |
-500
| Closed | -$24K | – | 1208 |
|
2021
Q2 | $24K | Hold |
500
| – | – | 0.01% | 709 |
|
2021
Q1 | $26K | Buy |
+500
| New | +$26K | 0.01% | 648 |
|